What criteria do CDC and WHO use to determine a death is vaccine-related?

Checked on December 13, 2025
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

This fact-check may be outdated. Consider refreshing it to get the most current information.

Executive summary

CDC and WHO use clinical investigation, timing, epidemiology and causality assessment frameworks — not single reports — to judge whether a death is vaccine-related; U.S. surveillance relies on passive reporting systems like VAERS plus active reviews and case-level clinical review by the Immunization Safety Office (CDC) and independent panels [1] [2]. Recent controversy arises because an FDA memo asserted links between COVID-19 vaccines and 10 child deaths without peer-reviewed evidence, while CDC presentations and reporting historically found “no known deaths” from post‑vaccine myocarditis in young people for certain periods [3] [4].

1. How public health agencies detect possible vaccine‑related deaths — surveillance, reports, and signal detection

Both the CDC and partners monitor for potential safety signals through multiple systems: passive reports to VAERS provide initial alerts, and CDC surveillance and published reviews estimate mortality rates by linking VAERS data to vaccination denominators to look for unexpected patterns [1]. The CDC also runs active surveillance and publishes findings in outlets such as MMWR; these multiple streams are intended to flag clusters or higher-than-expected events rather than to by themselves establish causality [2] [1].

2. What “linked” or “vaccine‑related” means in practice — clinical and epidemiologic criteria

Determinations rest on clinical case review (medical records, autopsy/lab results), temporal association (did the adverse event occur within a plausible risk window), biological plausibility, and epidemiologic evidence that events exceed background rates in similar unvaccinated populations; CDC guidance documents and peer‑reviewed analyses describe using denominators and comorbidity data to contextualize deaths reported after vaccination [1] [5]. Agencies therefore separate “death after vaccination” (a report) from “death caused by vaccination” (a conclusion requiring multiple converging lines of evidence) [1].

3. Why passive reports can be misleading — limitations of VAERS and early studies

VAERS is a passive system that depends on voluntary reporting and can include incomplete information and coincidental events; researchers using VAERS must account for underreporting, inconsistent detail, and lack of denominators, which is why CDC studies pair VAERS reviews with vaccination totals and clinical follow‑up to estimate mortality rates and identify comorbidities as alternate causes [1]. Critics cite the system’s limits when advocates highlight raw counts of post‑vaccine deaths, but published CDC and academic work explicitly note those methodological constraints [1].

4. Recent flashpoint: FDA memo, media claims, and CDC’s prior findings

Late‑2025 reporting that an FDA memo linked 10 child deaths to COVID‑19 vaccines triggered debate; Reuters summarized the memo and noted the FDA’s review had not been peer‑reviewed, and that CDC data show 1,071 COVID‑19 deaths in ages 5–18 during a multi‑year period — context that public health agencies use when weighing vaccine risks against disease harms [3]. At the same time, the CDC’s Immunization Safety Office earlier presented that there were “no known deaths or cardiac transplants” among 12–29 year olds with post‑vaccine myocarditis for a defined period, illustrating disagreement between agency presentations and later claims [4].

5. Competing interpretations and implicit agendas in recent coverage

Reporting shows divergent viewpoints: some former and current officials and scientists question the FDA memo’s conclusions and note lack of peer review, while other commentators and agency staff argue signals exist and merit stricter regulation; press pieces and opinion outlets sometimes amplify one side without the full methodological detail, and advocates on both sides have potential institutional or political incentives that shape framing [6] [7] [8]. Readers should note that high‑profile personnel changes and political actors have influenced public debate about vaccine policy and communication [9] [3].

6. What the public should expect from authoritative conclusions — transparency and peer review

Authoritative determinations that a death is vaccine‑caused are built from published, peer‑reviewed analyses or comprehensive agency reports that include clinical case reviews, pathology, epidemiologic adjustment for background rates, and reproducible methods; unreviewed internal memos or raw passive‑report counts do not meet that bar. The FDA’s and CDC’s published practices emphasize stepwise signal detection followed by targeted investigation before reaching causality conclusions [1] [2].

Limitations: available sources document agency methods, published analyses, and recent media controversy but do not provide a single, line‑by‑line “checklist” from WHO or CDC that maps every decision point; neither organization’s full internal deliberations in these specific recent cases are in the provided reporting (not found in current reporting).

Want to dive deeper?
How do CDC and WHO define vaccine-related death versus coincidental death?
What clinical and laboratory evidence is required to attribute a death to vaccination?
How do national vaccine safety committees and autopsy findings influence causality assessments?
What role do temporal association and background mortality rates play in determining vaccine-related deaths?
How transparent are CDC and WHO processes and where can case reports and reviews be accessed?